Quest Diagnostics Incorporated (LON:0KSX)
London · Delayed Price · Currency is GBP · Price in USD 180.54
-1.68 (-0.92%)
At close: Oct 23, 2025
Quest Diagnostics Market Cap
Quest Diagnostics has a market cap or net worth of 15.23 billion as of October 24, 2025. Its market cap has increased by 20.16% in one year.
Market Cap
15.23B
Enterprise Value
19.79B
Revenue
8.07B
Ranking
n/a
PE Ratio
21.26
Stock Price
180.54
Market Cap Chart
Since December 17, 1996, Quest Diagnostics's market cap has increased from 240.44M to 15.23B, an increase of 6,235.32%. That is a compound annual growth rate of 15.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 15.23B | 13.25% |
| Dec 31, 2024 | 13.45B | 10.51% |
| Dec 29, 2023 | 12.17B | -17.69% |
| Dec 30, 2022 | 14.79B | -5.66% |
| Dec 31, 2021 | 15.67B | 33.25% |
| Dec 31, 2020 | 11.76B | 8.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.78B |
| GSK plc | 66.21B |
| Haleon | 31.57B |
| Smith & Nephew | 11.67B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 3.92B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.74B |